You are currently viewing February 2023
1 results showing for: 'ocrelizumab'
Inj 30 mg per ml, 10 ml vial
- Brand Ocrevus
- Subsidy $9346.00
- Measure / Qty per 1
Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.
- Rectangle page icon symoblising a PDF. PDF
- Two duplicate pages icon. Click to copy
- Restriction. Restriction
- HSS Hospital Supply Status
- PSS Principal Supply Status
- dv DV Limit Gives the maximum volume that can be purchased of other brands
Email email@example.com to provide feedback: compliments, suggestions and complaints about the Online Pharmaceutical Schedule.